共 32 条
[1]
B-type natriuretic peptide levels diagnostic and prognostic in congestive heart failure: what’s next. Maisel A. Circulation . 2002
[2]
Effects of intravenous brain natriuretic peptide on regional sympathetic activity in patients with chronic heart failure as compared with healthy control subjects. Brunner-La Rocca HP,Kaye DM,Woods RL,et al. Journal of the American College of Cardiology . 2001
[3]
Natriuretic peptides: Physiology, therapeutic potential and risk stratification in ischemic heart disease. Stein BC,Levin RI. American Heart Journal . 1998
[4]
A review of the clinical utility of NT-pro BNP in the diagnosis, prognosis, and therapy monitoring of patients with congestive heart failure. Ambrose TM. J Clin Ligand Assay . 2003
[5]
Differential effects of protein kinase C, ras, and raf-1 kinase on the induction of the cardiac B-type natriuretic peptide gene through a critical promoter-proximal MCAT element. Thuerauf DJ,Glembotski CC. Journal of Biological Chemistry . 1997
[6]
Interaction of myocytes and non-myocytes is necessary for mechanical stretch to induce ANP/BNP production in cardiocyte culture. Harada M,Saito Y,Kuwahara K,et al. Journal of Cardiovascular Pharmacology . 1998
[7]
Brain natriuretic peptide in plasma, atria, and ventricles of vasopressin and phenylephrine-infused conscious rats. Magga J,MarttilaM,Mantymaa P,et al. The Journal of Endocrinology . 1994
[8]
Regional cardiac expression and concentration of natriuretic peptides in patients with severe chronic heart failure. Hystad ME,Geiran OR,Attramadal H,et al. Acta Physiologica Scandinavica . 2001
[9]
Biological variation of the natriuretic peptides and their role in monitoring patients with heart failure. Wu A,Smith A. European Journal of Heart Failure . 2004
[10]
The natriuretic peptides in the pathophysiology of congestive heart failure. Chen HH,Burnett JC. Current Cardiology Reports . 2000